DOCSLIB.ORG

Idiopathic Inflammatory Myopathies – a Guide to Subtypes, Diagnostic

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Idiopathic Inflammatory Myopathies – a Guide to Subtypes, Diagnostic REVIEW Clinical Medicine 2017 Vol 17, No 4: 322–8 Idiopathic inflammatory myopathies – a guide to subtypes, diagnostic approach and treatment A u t h o r s : A l e x a n d e r O l d r o y d , A J a m e s L i l l e k e r B a n d H e c t o r C h i n o y C The idiopathic infl ammatory myopathies are a group of condi- E p i d e m i o l o g y tions characterised by infl ammation of muscles (myositis) and other body systems. The diagnosis can be challenging because The IIMs are relatively rare conditions with an overall reported incidence of 11/million person-years (10 for men and 13 for of the many potential clinical features and extra-muscular 3 manifestations, which may be seemingly unrelated. An accu- women) and a prevalence of 14/100,000. ABSTRACT rate diagnosis requires up-to-date understanding of the clini- The peak age range of IIM onset is 45–60 years for adults and cal manifestations, different clinical subtypes and appropriate 5–15 years for children. Apart from inclusion body myositis (IBM), all IIM subtypes occur more commonly in women interpretation of investigations, including newly described 4 serological subtypes. This review will detail the approach to (ratio 2:1); IBM occurs twice as commonly in men as women. the diagnosis of an idiopathic infl ammatory myopathy, based on up-to-date knowledge. The recently updated classifi cation S u b t y p e s criteria and treatment options will also be described. Traditionally, the IIMs have been divided into subtypes according to their clinical features. Recent advances have K E Y W O R D S : Dermatomyositis , idiopathic infl ammatory myopa- identified that more clinically distinct subtypes exist than were thies , inclusion body myositis , myositis , polymyositis originally recognised. Introduction Dermatomyositis and polymyositis The idiopathic inflammatory myopathies (IIMs) are a group Dermatomyositis (DM) and polymyositis (PM) are both characterised by myositis (muscle inflammation) and systemic of autoimmune conditions characterised by inflammation 5,6 of muscle (myositis) and other organ systems, resulting in involvement. Myositis usually involves the proximal widespread organ dysfunction, increased morbidity and early musculature of the limbs leading to weakness and fatigue, mortality. Knowledge of the clinical manifestations of the IIMs especially on tasks such as standing from a seated position or and our ability to treat them have dramatically progressed reaching up for highly placed objects. since publication of the Bohan and Peter criteria in 1975.1,2 T h i s The systemic manifestations (ie involvement of organs other review aims to outline the clinical features of the IIMs, current than skeletal muscle) are important aspects of each disease. Possible systemic features include dysphagia, 7 dysphonia, classification criteria, the association of autoantibodies to 8 9 clinical features and current recommended treatment. interstitial lung disease (ILD), subcutaneous calcification, dilated cardiomyopathy, arrhythmias, atrioventricular defects and constitutional features, such as fatigue, fever and weight loss. DM is particularly associated with an increased risk of Authors: A NIHR academic clinical fellow (rheumatology), Centre for cancer development (cancer-associated myositis). Musculoskeletal Research, University of Manchester, Manchester, Myositis can occur without any other systemic manifestations. UK and NIHR Manchester Biomedical Research Centre, Central This so-called ‘lone PM’ is a rare occurrence and can pose a Manchester NHS Foundation Trust, Manchester Academic Health diagnostic challenge in differentiating this from other causes of Science Centre, Manchester, UK ; B clinical research fellow, NIHR muscle weakness. Manchester Biomedical Research Centre, Central Manchester NHS DM can be distinguished from PM by its typical cutaneous Foundation Trust, Manchester Academic Health Science Centre, features, which include Gottron’s papules (Fig 1 ), Gottron’s sign, Manchester, UK and Greater Manchester Neurosciences Centre, heliotrope rash (Fig 2 ), V-sign rash, mechanic’s hands (Fig 3 ), Salford Royal NHS Foundation Trust, Manchester Academic Health shawl sign rash and erythroderma. 10,11 Gottron’s papules are Science Centre, Salford, UK ; C senior clinical lecturer (rheumatology), red, scaly papules that occur over the dorsal aspect of the NIHR Manchester Biomedical Research Centre, Central Manchester metacarpophalangeal, proximal and distal interphalangeal NHS Foundation Trust, Manchester Academic Health Science joints, whereas Gottron’s sign is the same red, scaly papular Centre, Manchester, UK and Salford Royal NHS Foundation Trust, rash occurring elsewhere on the body. These cutaneous lesions Manchester Academic Health Science Centre, Salford, UK typically worsen with sun exposure. 322 © Royal College of Physicians 2017. All rights reserved. CMJv17n4-Oldroyd.indd 322 7/12/17 10:54 AM Idiopathic inflammatory myopathies Fig 1. Gottron’s papules over metacarpophalangeal and interphalangeal joints in a patient with dermatomyositis. Reproduced with permission from 11 Dugan et al. Fig 3. Mechanic’s hands: scaling, cracking and fi ssuring with bleeding along the lateral and palmar aspects of the fi ngers. Reproduced with permission from Dugan et al. 11 J u v e n i l e D M Juvenile DM has similar clinical features to adult DM and is characterised by myositis, cutaneous features and systemic and feet. 14 Fever, Raynaud’s phenomenon and mechanic’s involvement in patients under the age of 18 years.12 Features hands are also characteristic of the antisynthetase syndrome. particular to juvenile DM include cutaneous ulcerations, Antisynthetase syndrome is defined by the presence of an calcinosis cutis and vasculopathy. antisynthetase autoantibody and ≥1 of the following: > m y o s i t i s A m y o p a t h i c D M > I L D DM can exist without myositis, this uncommon subtype is > R a y n a u d ’ s p h e n o m e n o n termed clinically amyopathic DM. 13 Apart from muscle > M e c h a n i c ’ s h a n d s involvement, the clinical features of clinically amyopathic DM > a r t h r i t i s are the same as typical DM in terms of risk of ILD, cutaneous > f e v e r . manifestations and malignancy. Hypomyopathic disease may be seen in DM patients with magnetic resonance or muscle biopsy Immune-mediated necrotising myopathy evidence of myositis without weakness. Confusingly, patients may also present with histological features of DM without an Immune-mediated necrotising myopathy (IMNM), a rare overt rash (dermatomyositis sine dermatitis). but severe IIM subtype, is characterised by muscle necrosis and regeneration resulting in proximal muscle weakness. 15 In contrast to the previously discussed IIMs, inflammatory Antisynthetase syndrome infiltrates on muscle biopsy are not a predominant feature. The antisynthetase syndrome is a particularly severe IIM IMNM can be idiopathic, may follow viral infections or be subtype associated with myositis, ILD and inflammatory associated with statin use, malignancy or connective tissue symmetrical polyarthritis of the small joints of the hands diseases (CTDs), particularly scleroderma. The statin-associated form of IMNM is associated with autoantibodies directed against HMGCR (3-hydroxy-3-methyl-glutaryl-coenzyme A reductase) and characteristically does not improve despite withdrawal of the statin. IMNM is also associated with presence of the anti-signal recognition particle autoantibody. In the cancer-associated cases, treatment of malignancy (if possible) can lead to resolution of the myopathy. Inclusion body myositis IBM is a condition characterised by both inflammatory and degenerative changes within the muscle. 16 IBM occurs in patients aged over 50 years. The muscle weakness pattern is notable for both proximal and distal involvement with asymmetry being a common feature. The pattern of muscle weakness particular to IBM is early involvement of the finger flexors, ankle dorsiflexors and knee extensors. Head drop and camptocormia may manifest Fig 2. Heliotrope rash over the left eyelid with associated periorbital due to axial muscle involvement. Dysphagia occurs in over half of 17 oedema. Reproduced with permission from Dugan et al. 11 all patients with IBM. The condition follows a slowly progressive © Royal College of Physicians 2017. All rights reserved. 323 CMJv17n4-Oldroyd.indd 323 7/12/17 10:54 AM Alexander Oldroyd, James Lilleker and Hector Chinoy course and is unresponsive to immunotherapy. High degrees of Typical presentation of IIMs disability are seen, especially due to falls and weakness of grip. Diagnosis of an IIM can be straightforward if a patient presents Association with cancer with typical muscle weakness, clear multisystem involvement and a consistent serological profile. However, many patients in The association between the IIMs and increased risk of cancer clinical practice present with non-specific clinical features, such has been well reported. 18–23 The risk of cancer in the IIMs is as fever, fatigue, myalgia and arthralgia. between 2 and 7 times higher than the general population. Acute or subacute symmetrical muscle weakness of the The risk is highest in DM (2–7 times higher) compared to PM proximal arm and leg muscles is typical of the IIMs. Muscle (2 times higher). The risk of malignancy is highest in the year weakness may cause a patient to complain about difficulty in prior to and the year after IIM onset. DM confers a particularly combing their hair or progressive difficulty in rising from a higher risk of lung, ovarian and breast cancer, whereas PM chair. Weakness of other muscle groups may cause dysphonia is more associated with non-Hodgkin lymphomas, lung and or dysphagia. bladder cancer. As previously described, a diagnosis of DM can be suspected Current cancer screening recommendations for a patient newly in the presence of muscle weakness and typical DM cutaneous diagnosed with PM or DM comprise comprehensive history features. and examination, including rectal, breast, pelvic and testicular A patient may first present with an extra-muscular examination.
Load more

Recommended publications
  • Muscle Imaging 17 William Palmer and M
    Muscle Imaging 17 William Palmer and M. K. Jesse Learning Objectives 17.2 Imaging Modalities in Skeletal Muscle • Review the role of imaging in muscle diseases. Evaluation • Detect and classify acute muscle injury by imaging. Radiograph, while excellent for bone pathology, has limited • Review unique imaging features in idiopathic utility in the evaluation of muscle. Although the majority of infammatory myopathy. muscle pathology is occult on routine radiographic images, • Identify the imaging features of other common X-ray may be useful in a few conditions. Certain infamma- infectious, traumatic, and vascular muscle tory or autoimmune myopathy, for example, is characterized pathologies. by unique soft tissue calcifcations of which radiographs • Discuss the differential considerations in muscle may be the most reliable modality for detection. Magnetic lesions. resonance imaging and ultrasound offer excellent special resolution, allowing for the detailed evaluation of muscle microanatomy. Ultrasound offers an added beneft of dynamic imaging but is less sensitive than MRI for muscle edema and low-grade injury. Because of the superior sensi- 17.1 Introduction to Muscle Imaging tivity in detecting subtle injury, MR imaging evaluation is largely considered the diagnostic gold standard. Evaluation and characterization of skeletal muscle pathology is a frequently encountered indication for musculoskeletal imaging. Causes of muscle pathology are diverse and include 17.3 Traumatic Muscle Injuries traumatic, autoimmune, infectious, infammatory, neuro- logic, and neoplastic. Each etiology while dramatically dif- Muscle injury is common among athletes and poses a serious ferent in the pathophysiology may present with similar limitation to continued performance. The location and extent imaging features. An understanding of the subtle differences of a muscle injury has implications on the recovery and func- in imaging features between the pathologic conditions may tional outcome.
    [Show full text]
  • Azathioprine in Connective Tissue Disease-Associated Interstitial Lung Diseases
    Disease ng s u & Aldehaim et al., Lung Dis Treat 2019, 5:1 L T f r o e a l t DOI: 10.4172/2472-1018.1000132 a m n r e u n o t J Journal of Lung Diseases & Treatment ISSN: 2472-1018 Research Article Open Access Azathioprine in Connective Tissue Disease-Associated Interstitial Lung Diseases. How Valuable? Aldehaim AY1*, AboAbat A1,2 and Alshabanat A1,3 1Department of Medicine, King Saud University, Riyadh, Saudi Arabia 2Department of Medicine, University of Toronto, Toronto, Canada 3Department of Medicine, McMaster University, Hamilton, Canada Abstract Objective: To systematically review the use of azathioprine as a treatment for connective tissue disease- associated interstitial lung disease (CTD-ILD) in terms of effectiveness and safety. Materials and methods: A literature search was performed using the PubMed, EMBASE, CINAHL, Cochrane, and Scopus databases. The search was restricted to articles published in English from 1950 to March 2018 that examined the use of azathioprine in patients with CTD-ILD and determined its effects on a primary or secondary endpoint. This review included studies that measured the impacts of azathioprine in terms of effectiveness and safety. Results: The search identified 15 studies with a total of 424 subjects. Two hundred twenty patients received azathioprine. A majority of the studies failed to provide clear evidence for the effectiveness of azathioprine. The reported adverse events were: death 4.5% (n=10), infection 1.3% (n=3), myelosuppression 0.9% (n=2), and malignancy 0.45% (n=1). The rate of azathioprine discontinuation due to treatment failure was 2.7% (n=6).
    [Show full text]
  • Brachio-Cervical Inflammatory Myopathy with Associated Scleroderma Phenotype and Lupus Serology Andrew F
    Clinical/Scientific Notes Andrew F. Gao, MD BRACHIO-CERVICAL INFLAMMATORY myopathy with the distinctive prominent B-cell infil- Philip A. Saleh, MD MYOPATHY WITH ASSOCIATED SCLERODERMA trates and endomysial MAC deposition (figure). Charles D. Kassardjian, PHENOTYPE AND LUPUS SEROLOGY The patient was treated with high-dose IV meth- MD ylprednisolone for 4 days, followed by 1 mg/kg oral Ophir Vinik, MD Brachio-cervical inflammatory myopathy (BCIM) is prednisone and a gradual taper and azathioprine. David G. Munoz, MD a unique clinicopathologic entity characterized by She received monthly IV immunoglobulin. At 1 neck and upper extremity weakness with relative spar- 5-month follow-up, strength improved 4 /5 in the Neurol Neuroimmunol affected muscles. The CK level declined to 167 IU/L. Neuroinflamm ing of lower extremities and commonly associated 2018;5:e410; doi: 10.1212/ with connective tissue diseases or myasthenia gravis Dysphagia improved, and G-tube feeding could be NXI.0000000000000410 and serum autoantibodies (e.g., antinuclear antibody discontinued with resumption of solid oral diet. [ANA], anti–double stranded DNA [dsDNA], and Discussion. Our case is a prototypical example of anti–acetylcholine receptor).1 Muscle pathology is BCIM, demonstrating the clinicopathologic features distinctive, with prominent B-cell infiltrates and en- first described by Pestronk.1 They reported that the domysial membrane attack complex (MAC; C5b-9) most commonly associated conditions were myasthe- deposition. Despite the detailed original series, there nia gravis (40%) and rheumatoid arthritis (20%). have been no subsequent reports (besides abstracts2,3) Muscle biopsies showed extensive inflammatory infil- demonstrating the full clinicopathologic features of trates with at least 1 prominent CD201 B-cell focus, BCIM.
    [Show full text]
  • SUPPLEMENTARY MATERIAL Supplementary 1. International
    SUPPLEMENTARY MATERIAL Supplementary 1. International Myositis Classification Criteria Project Steering Committee Supplementary 2. Pilot study Supplementary 3. International Myositis Classification Criteria Project questionnaire Supplementary 4. Glossary and definitions for the International Myositis Classification Criteria Project questionnaire Supplementary 5. Adult comparator cases in the International Myositis Classification Criteria Project dataset Supplementary 6. Juvenile comparator cases in the International Myositis Classification Criteria Project dataset Supplementary 7. Validation cohort from the Euromyositis register Supplementary 8. Validation cohort from the Juvenile dermatomyositis cohort biomarker study and repository (UK and Ireland) 1 Supplementary 1. International Myositis Classification Criteria Project Steering Committee Name Affiliation Lars Alfredsson Institute for Environmental Medicine, Karolinska Institutet, Stockholm, Sweden Anthony A Amato Department of Neurology, Brigham and Women’s Hospital, Harvard Medical School, Boston, USA Richard J Barohn Department of Neurology, University of Kansas Medical Center, Kansas City, USA Matteo Bottai Institute for Environmental Medicine, Karolinska Institutet, Stockholm, Sweden Matthew H Liang Division of Rheumatology, Immunology and Allergy, Brigham and Women´s Hospital, Boston, USA Ingrid E Lundberg (Project Director) Rheumatology Unit, Department of Medicine, Karolinska University Hospital, Solna, Karolinska Institutet, Stockholm, Sweden Frederick W Miller Environmental
    [Show full text]
  • Pulmonary Hypertension in Antisynthetase Syndrome: Prevalence, Aetiology and Survival
    ORIGINAL ARTICLE PULMONARY VASCULAR DISEASE Pulmonary hypertension in antisynthetase syndrome: prevalence, aetiology and survival Baptiste Hervier1, Alain Meyer2,Ce´line Dieval3, Yurdagul Uzunhan4,5, Herve´ Devilliers6, David Launay7, Matthieu Canuet8, Laurent Teˆtu9, Christian Agard10, Jean Sibilia2, Mohamed Hamidou10, Zahir Amoura1, Hilario Nunes4,5, Olivier Benveniste11, Philippe Grenier12, David Montani13,14 and Eric Hachulla7,14 Affiliations: 1Internal Medicine Dept 2 and INSERM UMRS-945, French Reference Center for Lupus, Hoˆpital Pitie´-Salpeˆtrie`re, APHP, University of Paris VI Pierre and Marie Curie, Paris, 2Rheumatology Dept, French Reference Center for Systemic Rare Diseases, Strasbourg University Hospital, Strasbourg, 3Internal Medicine and Infectious Diseases Dept, St-Andre´ Hospital, University of Bordeaux, Bordeaux, 4University of Paris 13, Sorbonne Paris Cite´, EA 2363, Paris, 5Dept of Pneumology, AP-HP, Avicenne Hospital, Bobigny, 6Internal Medicine and Systemic Disease Dept, University Hospital of Dijon, Dijon, 7Internal Medicine Dept, French National Center for Rare Systemic Auto-Immune Diseases (Scleroderma), Claude Huriez Hospital, Lille 2 University, Lille, 8Pneumology Dept, Strasbourg University Hospital, Strasbourg, 9Pneumology Dept, Larrey Hospital, Paul Sabatier University, Toulouse, 10Internal Medicine Dept, Hoˆtel Dieu, Nantes University, Nantes, 11Internal Medicine Dept 1, French Reference Center for Neuromuscular Disorders, Hoˆpital Pitie´-Salpeˆtrie`re, APHP, University of Paris VI Pierre and Marie Curie, Paris, 12Radiology Dept, Hoˆpital Pitie´-Salpeˆtrie`re, APHP, University of Paris VI Pierre and Marie Curie, Paris, and 13Pneumology Dept, APHP, DHU Thorax Innovation, INSERM UMRS-999, Centre de Re´fe´rence de l’Hypertension Pulmonaire Se´ve`re, Hoˆpital Universitaire de Biceˆtre, Le Kremlin-Biceˆtre, Paris, France. 14These authors contributed equally to this work. Correspondence: B. Hervier, Service de Me´decine Interne 2, Centre National de re´fe´rence du Lupus, 47–83 boulevard de l’hoˆpital, 75651 Paris cedex 13, France.
    [Show full text]
  • Treatment of Myositis Ossificans with Acetic Acid Phonophoresis: a Case Series Angela Bagnulo, BA, DC, FRCCSS(C)1 Robert Gringmuth, DC, FRCCSS(C), FCCPOR(C)2
    ISSN 0008-3194 (p)/ISSN 1715-6181 (e)/2014/353–360/$2.00/©JCCA 2014 Treatment of Myositis Ossificans with acetic acid phonophoresis: a case series Angela Bagnulo, BA, DC, FRCCSS(C)1 Robert Gringmuth, DC, FRCCSS(C), FCCPOR(C)2 Objective: To create awareness of myositis ossificans Objectif : Sensibilisation à la myosite ossifiante (MO) (MO) as a potential complication of muscle contusion comme complication possible de contusions musculaires by presenting its clinical presentation and diagnostic grâce à la présentation de son tableau clinique et de features. An effective method of treatment is offered for ses symptômes. Une méthode efficace de traitement est those patients who develop traumatic MO. offerte pour les patients qui sont atteints de myosite Management: Patients in this case series developed ossifiante traumatique. traumatic MO, confirmed on diagnostic ultrasound. Traitement : Les patients de cette série de cas Patients participated in a treatment regimen consisting souffrent de myosite ossifiante traumatique, confirmée of phonophoresis of acetic acid with ultrasound. par échographie. Les patients ont participé à un régime Outcome: In all cases, a trial of phonophoresis de traitement consistant en une irrigation d’acide therapy significantly decreased patient signs, symptoms acétique par phonophorèse. and the size of the calcification on diagnostic ultrasound Résultats : Dans tous les cas, un essai de traitement in most at a 4-week post diagnosis mark. par phonophorèse a diminué considérablement les Discussion: Due to the potential damage to the muscle signes et les symptômes des patients ainsi que la taille de and its function, that surgical excision carries; safe la calcification détectée par échographie dans la plupart effective methods of conservative treatment for MO are des cas 4 semaines après le diagnostic.
    [Show full text]
  • Predicting Recovery Time from the Initial Assessment of a Quadriceps Contusion Injury
    CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Alonso et al: Predicting recovery time from the initial assessment of a quadriceps contusion injury Predicting recovery time from the initial assessment of a quadriceps contusion injury Albert Alonso1, Phillip Hekeik2 and Roger Adams3 1Canterbury Bulldogs Rugby League Club, Sydney 2Private practice, Sydney 3The University of Sydney Six quadriceps contusion tests were evaluated for inter-rater reliability and ability to predict the recovery time of 100 injured rugby players. All subjects were treated with a standardised and disciplined treatment program incorporating cryokinetics and modified training. Muscle firmness ratings, thigh circumference and passive knee flexion range of movement (ROM) measurements, and the unilateral palpation, brush-swipe and tap tests were all found to have substantial to excellent reliability (range: 0.66-1.00). Multiple regression analysis demonstrated that 64 per cent of the variance in the time taken to return to full training could be accounted for by an equation involving the uninjured-injured difference in knee range, relative firmness rating of the injured muscle, difference in circumferences at the suprapatellar border, being able to play on following injury and the time delay before starting treatment. [Alonso A, Hekeik P and Adams R (2000): Predicting recovery time from the initial assessment of a quadriceps contusion injury. Australian Journal of Physiotherapy 46: 167-177] Key words: Contusions; Myositis; Predictive Value of Tests; Thigh Introduction horse injuries, are the result of a direct blow to the anterior thigh with high velocity compressive forces which are excessive (Young et al 1993, Zarins and Starkey and Ryan (1996) note that obtaining Ciullo 1983).
    [Show full text]
  • Antisynthetase Syndrome and Rheumatoid Arthritis: a Rare Overlapping Disease
    Case Report Annals of Clinical Case Reports Published: 15 Jul, 2020 Antisynthetase Syndrome and Rheumatoid Arthritis: A Rare Overlapping Disease Makhlouf Yasmine*, Miladi Saoussen, Fazaa Alia, Sallemi Mariem, Ouenniche Kmar, Leila Souebni, Kassab Selma, Chekili Selma, Zakraoui Leith, Ben Abdelghani Kawther and Laatar Ahmed Department of Rheumatology, Mongi Slim Hospital, Tunisia Abstract The association between Antisynthetase Syndrome (ASS) and rheumatoid arthritis is extremely rare. In this case report, we are describing a 16 years long standing history of seropositive RA before its uncommon association to an ASS. A 55-year-old female patient presented at the first visit with symmetric polyarthritis and active synovitis affecting both hands and ankles. Laboratory investigations showed positive rheumatoid factors, positive anti-CCP antibodies and negative ANA. The X-rays were consistent with typical erosive in hands. Thus, the patient fulfilled the ACR 1987 criteria of RA in 2000 at the age of 37. Methotrexate was firstly prescribed. However, it was ineffective after 4 years. Then, the patient did well with Leflunomide until January 2017, when she developed exertional dyspnea. High-resolution CT of the lung revealed Nonspecific Interstitial Pneumonia (NSIP). Autoantibodies against extractable nuclear antigens were screened and showed positive results for anti-Jo1 autoantibodies. She was diagnosed with ASS complicating the course of RA. Keywords: Antisynthetase syndrome; Rheumatoid arthritis; Overlap syndrome; Nonspecific interstitial pneumonia Key Points • Antisynthetase Syndrome should be considered as a clinical manifestation of overlap syndromes, particularly in active RA patients with pulmonary signs and anti-Jo-1 antibody. OPEN ACCESS • An early diagnosis of antisynthetase syndrome in an overlap syndrome is important, as *Correspondence: treatment may need adjustment.
    [Show full text]
  • Dropped Head Syndrome Due to Neuromuscular Disorders: Clinical
    Neurology International 2019; volume 11:8198 Dropped head syndrome due inflammatory polyneuropathy (CIDP),11 to neuromuscular disorders: neuromuscular causes include myasthenia Correspondence: Ahmet Z. Burakgazi, gravis (MG),12-14 Lambert-Eaton myasthe- Neuroscience Section, Department of Clinical manifestation and nia syndrome (LEMS),15 muscular causes Medicine, Virginia Tech Carilion School of evaluation includes primary inflammatory such as Medicine, 3 Riverside Circle, Roanoke, VA polymyositis,16 scleromyositis,17,18 isolated 24016, USA. inflammatory axial myopathy,19 primary Tel.: +1.540-521-4592. Ahmet Z. Burakgazi, Perry K. E-mail: [email protected] Richardson, Mohammad Abu-Rub non-inflammatory such as nemaline myopa- 20-22 thy, mitochondrial myopathy, congeni- Key words: Dropped head syndrome, neuro- Virginia Tech Carilion School of 23 24 tal myopathy, FSHD, and isolated neck muscular disease. Medicine, Roanoke, VA, USA extensor myopathy (INEM).19 Contributions: the authors contributed equally. Conflict of interest: the authors declare no Abstract General approach: clinical mani- potential conflict of interest. festation and evaluation In this article, we discuss the clinical Funding: none. approach to patients with dropped head syn- DHS occurs as a result of weakness of drome and identify the various neuromus- posterior neck muscles. It usually disap- Received for publication: 11 June 2019. cular causes of dropped head syndrome pears with supine position. The common Accepted for publication: 18 June 2019. including muscle, neuromuscular junction, chief complaints are “chin on the chest” and This work is licensed under a Creative peripheral nerve and motor neuron etiolo- “difficulty maintaining a forward gaze”. It gies. We aim to increase awareness of Commons Attribution NonCommercial 4.0 may contribute to dysphagia and has cos- License (CC BY-NC 4.0).
    [Show full text]
  • Delayed Sciatic Nerve Injury Resulting from Myositis Ossificans Traumatica
    PM R 8 (2016) 484-487 www.pmrjournal.org Case Presentation Delayed Sciatic Nerve Injury Resulting From Myositis Ossificans Traumatica Zhe Guan, MS, Thomas J. Wilson, MD, Jon A. Jacobson, MD, Todd C. Hollon, MD, Lynda J.-S. Yang, MD, PhD Abstract A motorcyclist sustained multiple-system trauma, including a left buttock hematoma requiring decompression and evacuation. Presentation for severe hip pain and lower extremity weakness was delayed. Imaging revealed myositis ossificans traumatica compressing the sciatic nerve in the buttock. The patient underwent sciatic nerve decompression with resection of heterotopic calcification, resulting in improvement in pain and left lower extremity function. This case illustrates the contrast in differential diagnosis of peripheral nerve injury immediately posttrauma and that occurring in a slow, delayed fashion posttrauma. Myositis ossificans may be an underrecognized complication of trauma but should be considered in cases of delayed peripheral nerve injury after trauma. Introduction repair. His sacral and vertebral fractures were treated nonoperatively. During his hospital course, he was sus- Neurological deficits after peripheral nerve injury pected to have left gluteal compartment syndrome, a may occur either immediately due to direct injury at the rare disorder affecting 1 or more of the 3 anatomic site of impact or in a delayed fashion due to a variety of gluteal compartments: the gluteus maximus compart- processes that cause secondary insult, including hema- ment, the gluteus medius and minimus compartment, toma formation, delayed ischemia, or iatrogenic injury. and the tensor fasciae latae compartment. The disorder Pelvic trauma/fractures are associated with an typically presents with swelling, redness, and tender- increased risk of nerve injury, particularly to the sciatic ness over the buttock, ipsilateral hip pain, and sciatic nerve [1].
    [Show full text]
  • Anti-Synthetase Syndrome Podcast Transcript
    [Deepa]: Hello everyone and welcome to RareShare/Rare Genomics Institute second session of our podcast series, Ask the Expert. This podcast will focus on advances in Antisynthetase Syndrome from a clinical and research perspective. My name is Deepa Kushwaha, and I am the Program Manager for Rare Genomics Institute, hosting today, will be Dr. Jimmy Lin, RGI’s president. Dr. Lin, can you tell the listeners about RareShare/Rare Genomics Institute? [Jimmy]: Happy to Deepa, the Rare Genomics Institute is a non-profit that was established four years ago to be able to help rare disease patients access top researchers and actually also find funding and connect to potential researcher help find for a cure. RareShare joined us last year, the RGI and RareShare is a platform, an online community where rare disease patients can talk to each other and we actually bring more experts to be able to add to that conversation so we’re excited to work together as Rare Genomics and RareShare to hopefully provide some early answers and not all of them but to the millions and millions of people in the US and in the world affected by rare disease. So this is the second one of our disease specific podcast that we’re doing but also just want to let the listeners know we also have another set of podcast that we’re in the middle of preparing that’s general to all rare diseases such as ‘Overcoming Financial Barriers’ or ‘How to Navigate the Medical System” So those podcasts are in preparation and stay tuned.
    [Show full text]
  • Disorders of the Contractile Structures 54
    Disorders of the contractile structures 54 CHAPTER CONTENTS and is felt as a sudden, painful ‘giving way’ at the front of the Extensor mechanism 713 thigh. Alternatively, the muscular lesion may result from a direct contusion during contact sports (judo or American foot- Quadriceps strains and contusions . 713 ball), known as ‘Charley Horse’. Adherent vastus intermedius . 714 Patients who suffer an acute quadriceps strain will usually Tendinous lesions about the patella . 714 know right away. They are typically involved in sports requiring Rupture of the quadriceps tendon . 718 kicking, jumping, or initiating a sudden change in direction while running. Frequently, a sharp pain is felt, associated with Lesions of the infrapatellar tendon . 718 a loss in function of the quadriceps. Sometimes pain will not Lesions of the insertion at the tibial tuberosity . 719 fully develop during the athlete’s activity while the thigh is Patellar fracture . 719 warm; consequently, the extent of the injury is underesti- Patellofemoral disorders 719 mated. Stiffness, disability and pain then set in some time Introduction . 719 afterwards, e.g. late at night, and the following morning the patient can walk only with a limp.1 Mechanical theory . 719 Clinical examination shows a normal hip and knee, although Neural theory . 720 passive knee flexion is painful or both painful and limited, Clinical examination . 720 depending on the size of the rupture. Resisted extension of the Clinical manifestations . 722 knee is painful and slightly weak. As a rule, the lesion is in the 2 Strained iliotibial band 724 rectus femoris, usually at mid-thigh level. The affected muscle belly is hard and tender over a large area.
    [Show full text]